Carregando...
Attrition of Patients on a Precision Oncology Trial: Analysis of the I‐PREDICT Experience
BACKGROUND: Precision oncology uses molecular profiling of tumors to identify biomarker‐tailored therapies for patients in the hope of improving outcomes. Typically, only a minority of patients receives evaluable matched treatment. This study explored the reasons for attrition on a precision medicin...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Principais autores: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7648352/ https://ncbi.nlm.nih.gov/pubmed/32949172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13532 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|